Trevi Therapeutics, Inc.
USD16.77
-2.30 (-12.06%)
CEO
Jennifer L. Good
IPO Date
2019-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.28
Prev. Close
$19.07
Day Low
$16.62
Day High
$19.37
52W Low
$6.55
52W High
$20.22
Market Cap
$2.38B
Volume
2.84M
| 35,000 |
| $13.45 |
| 4 Jun 2026 | Meeker David P | director | A-Award | Acquired | 35,000 | $13.45 |
| 4 Jun 2026 | VANLENT ANNE | director | A-Award | Acquired | 35,000 | $13.45 |
| 4 Jun 2026 | Heffernan Michael Thomas | director | A-Award | Acquired | 35,000 | $13.45 |
| 20 Feb 2026 | Cassella James V | Chief Development Officer | A-Award | Acquired | 215,000 | $10.56 |
| 20 Feb 2026 | Galletta Christopher | See Remarks | A-Award | Acquired | 35,000 | $10.56 |
| 20 Feb 2026 | SCIASCIA THOMAS | Chief Scientific Officer | A-Award | Acquired | 85,000 | $10.56 |
| 20 Feb 2026 | GOOD JENNIFER L | director, officer: President & CEO | A-Award | Acquired | 675,000 | $10.56 |
| 20 Feb 2026 | Simon Farrell | Chief Commercial Officer | A-Award | Acquired | 160,000 | $10.56 |